When sourcing bulk 6-Iodo-4-quinazolinol (CAS 16064-08-7) for large-scale pharmaceutical synthesis, supply chain managers must address unique physicochemical challenges that intensify during winter transit. This halogenated heterocycle, also referred to as 6-Iodo-4-hydroxyquinazoline or 6-Iodoquinazolin-4-one, is a critical intermediate in kinase inhibitor manufacturing. Its crystalline powder form exhibits hygroscopic tendencies and static charge accumulation, demanding rigorous packaging protocols. At NINGBO INNO PHARMCHEM CO.,LTD., we engineer drop-in replacement solutions that match original specifications while optimizing cost and reliability. Our 6-Iodo-4-quinazolinol is produced under strict quality control, with batch-specific COAs detailing purity and trace metal limits. For a deeper dive into how our product compares to TCI I0832, refer to our analysis on trace metal limits in 6-Iodo-4-quinazolinol.
